Category: Encision Inc.Syndicate content

Encision names new CEO, raises $2M

December 18, 2013 by Chris Walker

Encision names Covidien veteran Greg Trudel as its new president & CEO and closes a $2 million private placement.

Encision names new CEO and raises $2M

Encision (PINK:ECIA) handed the corner office over to Greg Trudel and said it closed a private placement worth $2 million.

Encision drops hard following death of CEO

September 3, 2013 by Arezu Sarvestani

Colorado medical device maker Encision announces the death of CEO Fred Perner, 59, who passed away from a heart attack last week; Wall Street sends ECIA shares down 17%.

Encision drops hard following death of CEO

Encision co-founder resigns | Personnel Moves

January 23, 2013 by MassDevice staff

Encision co-founder Roger Odell resigns from his executive and board positions and moves to a non-executive officer role.

fired/hired

 Encision co-founder resigns as executive officer

MITA appoints new director of government relations | Personnel Moves

August 8, 2012 by MassDevice staff

The Medical Imaging Technology Alliance announces David Cooling's appointment as director of government relations.

fired/hired

 MITA appoints David Cooling as director of state, federal government relations

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific launches Pluromed's BackStop kidney stone treatment | Wall Street Beat

April 2, 2012 by MassDevice staff

Boston Scientific launches its BackStop kidney stone treatment, licensed from Pluromed, in the U.S. and certain international markets; also, Siemens lands 3rd year defense contract worth up to $1.9 billion; Bruker Corp. nabs all shares of SkyScan for an undisclosed amount; Viking expects 40% sales growth for Q1 2012; Smith & Nephew acquires LifeModeler for an undisclosed amount; Wound Care Innovations signs exclusive N.A.

MassDevice.com Wall Street Beat

Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

3M touts record sales and earnings per share for 2011 | Earnings Roundup

January 27, 2012 by MassDevice staff

3M's 4th-quarter profits beat The Street as it affirms its 2012 guidance, but shares stay flat; also, Hill-Rom's Q1 earnings slide 7%; Getinge sees 2011 profits rise 11% despite sales slide; ResMed's Q2 sales, earnings rise; Uroplasty pares Q3 losses on doubled sales; Encision swings to Q3 losses; and EnteroMedics' Q4, 2011 losses rise.

3M Co.

3M Co. (NYSE:MMM) beat expectations for its 4th-quarter profits and affirmed its guidance for 2012, but Wall Street remained unmoved, with shares staying flat in this morning's trading.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp